Federal grants to Oraliva, Inc.
Oraliva, Inc. in Research Triangle Park, North Carolina received $3.1 million in federal grants from fiscal 2021 to 2025, across 4 awards. Its largest program was Technology, Innovation, and Partnerships, with $1.5 million. In fiscal 2025 it was awarded $2.8 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$3.1 million
- Awards4
- Awarded in FY 2025$2.8 million
- Largest award$1.2 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 0 | $0 |
| FY 2022 | 0 | $0 |
| FY 2023 | 1 | $275,000 |
| FY 2024 | 0 | $0 |
| FY 2025 | 3 | $2.8 million |
Programs that fund Oraliva, Inc.
| Program | Awards | Amount |
|---|---|---|
| Technology, Innovation, and Partnerships | 2 | $1.5 million |
| Oral Diseases and Disorders Research | 1 | $1.2 million |
| Cancer Detection and Diagnosis Research | 1 | $400,000 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 2 | $1.6 million |
| National Science Foundation | 2 | $1.5 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Sttr phase II: portable single cell cytology and predictive analysis platform for the early detection of epithelial cancers -the broader impact/commercial potential of this small business technology transfer (STTR) phase II project is to optimize an accurate and efficient early stage, point of care | Technology, Innovation, and Partnerships | August 15, 2025 | $1.2 million |
| Ai-linked cytomics-on-a-chip to enable near-real time identification and management of oral lichenoid lesions in primary care - abstract oral cancer, which affects 54,000 americans per year, has one of the worst outcomes and highest expense rates of all cancers, in large part due to late-stage diagn | Oral Diseases and Disorders Research | April 15, 2025 | $1.2 million |
| Point of care diagnostic to improve access to gynecological screening in low-resource settings - oraliva and partners propose to develop a novel, low cost, fully integrated gynecological screening test that exhibits comparable accuracy at the point of care (POC) to current remote lab tests. Providin | Cancer Detection and Diagnosis Research | August 27, 2025 | $400,000 |
| Sttr phase i: portable single cell cytology and predictive analysis platform for the early detection of epithelial cancers -the broader impact/commercial potential of this small business technology transfer (STTR) phase i project will address the need for an accessible method to identify early-stage | Technology, Innovation, and Partnerships | February 13, 2023 | $275,000 |
Questions people ask
How much federal grant money does Oraliva, Inc. get?
$3.1 million in 4 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Oraliva, Inc. the most?
The Department of Health and Human Services, with $1.6 million in 2 awards. The National Science Foundation follow.
What is Oraliva, Inc.'s largest federal grant?
$1.2 million under Technology, Innovation, and Partnerships, with its first action in the period on August 15, 2025. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Oraliva, Inc.?
Its largest are Technology, Innovation, and Partnerships, Oral Diseases and Disorders Research and Cancer Detection and Diagnosis Research.
Other grant recipients in Research Triangle Park
- Research Triangle Institute
- Epicypher, Inc.
- T3D Therapeutics, Inc.
- Redbud Labs, Inc.
- Altis Biosystems, Inc.
- Dignify Therapeutics, LLC
- Zymtronix Catalytic Systems, Inc.
- 21MEDTECH LLC
Largest federal grant recipients in North Carolina · Federal grants in North Carolina